Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease

Oxid Med Cell Longev. 2019 Apr 4:2019:7480512. doi: 10.1155/2019/7480512. eCollection 2019.

Abstract

Geniposide, an iridoid glucoside, is a major component in the fruit of Gardenia jasminoides Ellis (Gardenia fruits). Geniposide has been experimentally proved to possess multiple pharmacological actions involving antioxidative stress, anti-inflammatory, antiapoptosis, antiangiogenesis, antiendoplasmic reticulum stress (ERS), etc. In vitro and in vivo studies have further identified the value of geniposide in a spectrum of preclinical models of diabetes mellitus (DM) and cardiovascular disorders. The antioxidative property of geniposide should be attributed to the result of either the inhibition of numerous pathological processes or the activation of various proteins associated with cell survival or a combination of both. In this review, we will summarize the available knowledge on the antioxidative property and protective effects of geniposide in DM and cardiovascular disease in the literature and discuss antioxidant mechanisms as well as its potential applications in clinic.

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants / pharmacokinetics
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Diabetes Mellitus / drug therapy*
  • Drug Evaluation, Preclinical
  • Humans
  • Iridoids / chemistry
  • Iridoids / pharmacokinetics
  • Iridoids / pharmacology
  • Iridoids / therapeutic use*
  • Models, Molecular*

Substances

  • Antioxidants
  • Iridoids
  • geniposide